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Polyinosinic-polycytidylic acid, a potent inducer of interferon (IFN) production and activator of some IFN- 
induced enzymes, inhibits PH]uridine incorporation into the RNA of vesicular stomatitis virus even in the 
absence of IFN synthesis, transiently triggers the breakdown of inositol phospholipids and activates the 
translocation of protein kinase C. Since IFNs also have similar activities these results suggest hat IFN 
induction and IFN function are realised through common biochemical pathways. 
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1. INTRODUCTION 
A variety of growth factors including 
interleukin-1 , interleukin-2, colony-stimulating 
factor, epidermal growth factor, fibroblast growth 
factor and platelet derived growth factor (PDGF) 
stimulate expression of interferon (IFN) genes [ 11. 
PDGF activates membrane phosphatidylinositol 
hydrolysis through a receptor-mediated interaction 
[2,3]. In addition, IFNs also stimulate the turnover 
of membrane phosphatidylinositol and transiently 
activate diacylglycerol and inositol trisphophate 
release [4,5]. As it was reported that 
polyinosinic : polycytidylic acid (poly(1). poly(C)) 
and PDGF activate the same genes in 3T3 cells [6], 
it is thus reasonable to suppose that the effects of 
poly(1). poly(C) and PDGF are realised by com- 
mon mechanisms. 
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On the basis of these data we postulate that (i) 
poly(1). poly(C) per se has IFN-like effects, (ii) ac- 
tivates inositol phospholipid breakdown and (iii) 
induces protein kinase C (PK-C) activity. 
2. MATERIALS AND METHODS 
UAC monolayer cell cultures grown in Microtest 
TC plates (Falcon) were infected with 50-100 
TCD&50 ~1 vesicular stomatitis virus (VSV), In- 
diana strain, and actinomycin D in a final concen- 
tration of 5 pg/ml was added. To allow virus 
absorption poly(1). poly(C) in different concentra- 
tions together with 40 kBq [3H]uridine in 50~1 
medium was given to each well after 1 h incuba- 
tion. After a 4 h incubation period the radioactivi- 
ty incorporated was measured as described in 
detail elsewhere [7]. 
Suspension cultures of UAC cells (lo6 cells/ml) 
were incubated with 40 kBq/ml my0-[2-~H]- 
inositol (Amersham). After 16 h the cells were 
washed three times in Dulbecco’s phosphate buf- 
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fered saline (PBS). Samples containing 5 x IO6 
cells in 1.0 ml PBS were treated with 50,&ml 
poly(I).poly(C) for the indicated intervals. This 
treatment was terminated by adding 4.0 ml of 
chloroform/methanol/HCl (2: 1: 0.0075) con- 
taining 50 pg/ml 2,6-di-t-butyl-4-methylphenol 
(BHT). The chloroform phase was evaporated 
under N2 and taken up in 100~1 chloroform. Ali- 
quots with authentic phosphatidylinositol (PI), 
phosphatidylinositol 4-phosphate (PIP) and 
phosphatidylinositol 4,5-diphosphate (PIP2) 
(Sigma) were spotted onto precoated HP TCL 
plates (Merck) and developed using chloroform/ 
methanol/3.3 M NH40H (43 :38: 12) as solvent. 
Visualisation took place under UV light after 
spraying the plates with 0.05% 8-anilino-l-naph- 
thalenesulphonic acid in methanol. The spots were 
then transferred to vials and counted in a toluene- 
based cocktail. 
Water-soluble metabolites were separated by 
anion-exchange chromatography according to Ber- 
ridge et al. [8]. 
Phospholipid-dependent PK-C activity was 
measured in the cytosol and detergent-solubilized 
membrane fraction according to Kikkawa et al. 
191. 
3. RESULTS AND DISCUSSION 
(i) Pretreatment of UAC cells with poly(1). 
poly(C) inhibited VSV-RNA synthesis and this 
effect proved to be dose dependent (not shown). In 
other experiments the antiviral activity of 
poly(1). poly(C) was followed by measuring viral 
RNA synthesis in the presence of actinomycin D 
(5 pg/ml) and poly(1) ’ poly(C) was given only after 
virus infection. In this condition synthesis of host 
mRNAs (among those that of IFN) are inhibited. 
Fig. 1 shows that 50 pg/ml poly(1). poly(C), even 
under this experimental condition, completely in- 
hibits viral RNA synthesis. In simultaneous ex- 
periments 500 U/ml IFN-a had only a modest 
effect. 
(ii) Suspension cultures of UAC cells were in- 
cubated overnight with myo-[2-3H]inosito1 and 
then treated with 50 pg/ml poly(1) .poly(C). Fig.2 
demonstrates that after poly(I). poly(C) treatment 
the amounts of [3H]phosphatidy1inositol 4-phos- 
phate and [3H]phosphatidylinosito1 4,5-diphos- 
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Fig. 1. Effect of poly(I).poly(C) on VSV-RNA 
replication in UAC cells. UAC monolayer cultures 
grown in Microtest TC plates (Falcon) were infected 
with 50-100 TCD&SOpl VSV, Indiana strain, and 
actinomycin D in a final concentration of 5 pg/ml was 
added. To allow virus absorption, poly(I).poly(C) in 
different concentrations together with 40 kBq 
[3H]uridine in 50 ~1 medium was given to each well after 
1 h incubation. Then after a 4 h incubation period the 
radioactivity incorporated was measured. Each point 
represents the mean inhibition f SD of isotope uptake 
into the viral RNA in % of the control values (n = 6). 
The column shows the inhibitory effect of 500 U/ml 
IFN-cu (EGIS, Pharmacochemical Works, Budapest). 
phate increased within 60 s and later decreased to 
below the control value. 
Similar results were observed by measuring 
water-soluble inositol l-phosphate (fig.3). Fig.3 
also shows that a relatively high dose of Li+ 
(12 mM), a potent inhibitor of myo-ino- 
sitol-1-phosphatase [lo], added together with 
poly(1). poly(C) does not alter this effect. 
(iii) Stimulation of phosphatidylinositol turn- 
over provoked by a wide variety of extracellular 
signals such as neurotransmitters, hormones, 
growth factors and many other biologically active 
substances appears to be an activator of PK-C 
[ 111. This enzyme is a key factor in signal transduc- 
tion. It has been shown that. phorbol myristate 
acetate (PMA), interleukin-2 and interleukin-3 
produce a rapid and transient redistribution of PK- 
C from the cytosol to the plasma membrane 
[12-141. Fig.4 shows that poly(I).poly(C) also in- 
duces PK-C transposition. Within a few minutes of 
Volume 226, number 1 FEBS LETTERS December 1987 
,I 0 I_,, 
0051 10 30 60 
Ttme (min) 
Fig.2. Changes of membrane phosphatidylinositol 
phosphates in UAC cells treated with poly(1) .poly(C) 
for different time intervals. Phosphatidylinositol 
phosphates (PIP, PIP2) were measured as described in 
detail in section 2. Counts (n = 4) were corrected for 
quenching and counting efficiency. (M) PIP; 
(M) PIP2. 
adding poly(I). poly(C) to the cells, the cytosolic 
PK-C activity began to fall rapidly, then slowly in- 
creased. The membrane-bound enzyme activity 
shows an opposite effect. 
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Fig.3. Changes of inositol l-phosphate in UAC cells 
treated with poly(I) . poly(C) for different time intervals. 
UAC cells were labelled and treated with 
poly(I).poly(C) (0) and poly(1). poly(C) + LiCl 
(12 mM) (0) as described in section 2. Counts (n = 4) 
are given in % of control values. 
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Fig.4. Time course of the effect of poly(I).poly(C) 
treatment of UAC cells on cytosolic (0) and particulate 
(0) PK-C. Suspension cultures of UAC cells were 
washed with PBS and then treated with 50pg/ml 
poly(I)~poly(C). Samples containing 2 X 10’ cells were 
homogenized by sonication for 3 x 20 s at 0°C in 0.5 ml 
of 20 mM Tris-HCl, pH 7.5, 2 mM EDTA, 0.5 mM 
EGTA, 1 mM phenylmethylsulphonyl fluoride buffer. 
The supernatant was saved (cytosolic fraction). The 
pellet was resuspended by brief sonication and 
solubilized (on ice for 1 h) in 0.5 ml homogenization 
buffer containing 1% Triton X-100. This suspension was 
centrifuged at 48000 x g for 30 min and the supernatant 
(particulate fraction) was retained. The reaction mixture 
contained, in a total volume of 80 ~1, 20 mM Tris-HCl, 
pH 7.5, 10 mM MgCl2, 0.2 mg/ml histone (Sigma, type 
III-S), 15 pl enzyme preparation (6 x 10’ cells) and 
either 1 mM EGTA or 1 mM CaCl2, 50pg/ml 
phosphatidylserine, 2 pg/ml diolein. The reaction was 
started by addition of [y-32P]ATP (40 kBq, 
200 TBq/mmol) and was stopped after 2 min by 
spotting aliquots (26~1) of the reaction mixture onto 
phosphocellulose paper in ice-cold 10% trichloroacetic 
acid. The filter papers were then washed in 5% 
trichloroacetic acid (four changes in washing solution). 
The papers were then transferred sequentially through 
methanol and acetone before drying and radioactivity 
was determined by scintillation counting. PK-C activity 
was defined as that seen in the presence of CaCl2 and 
lipids minus that seen in the presence of EGTA. PK-C 
activity is expressed as cpm of 32P incorporated per 
2 min per total volume of each cytosolic and membrane 
preparation. 
A considerable number of substances (specific 
antigens, mitogens, lymphokines, etc.) having a 
stimulating effect on phosphatidylinositol turn- 
1.5 
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over [ 15,161 proved to be inducers of different 
kinds of IFNs [17-221. In addition, compounds 
that activate PK-C, for example PMA or 
interleukin-2, also induce the expression of IFN-y 
genes [21,22]. A per se antiviral effect of PMA was 
also demonstrated [23]. 
All these findings, together with our present 
results, comprise strong evidence that a major 
pathway of induction and mode of action of IFNs 
are realised through a common signal transduction 
mechanism of the cells. This hypothesis helps to 
explain the growth factor-like effect of IFN 
[24,25], which is hardly compatible with its known 
antiproliferative effect and is in accordance with 
the finding that IFN-pretreated cells are much 
more sensitive to the cytotoxic effect of 
poly(I) - poly(C) than control cells [26]. 
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